跳至主要内容
临床试验/NCT06414369
NCT06414369已完成不适用

Effects of Diatermy in Patients With Fibromyalgia.

Camilo Jose Cela University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Pain (VAS)

研究概览

简要总结

Diathermy is a non-invasive pain therapy based on the local application of high-frequency electromagnetic waves. This procedure produces deep heat promotes tissue repair and influences pain sensitivity. The main characteristic of fibromyalgia (FM) is generalized musculoskeletal pain. This may be accompanied by muscle and joint stiffness, sleep and mood disorders, anxiety and depression, cognitive dysfunction, and chronic fatigue. Endemic in developed countries, with a higher prevalence among women than men, and the etiology is still unknown. Diagnosis is made on chronic generalized pain and through the presence of tender points. The objective of this study will be to analyze the efficacy of diathermy on pain in patients with fibromyalgia

详细描述

The researchers aimed will be to observe the effect of diathermy (DT) on chronic fatigue, anxiety, and depression; analyze whether there are improvements in the impact of the disease in patients with FM after the application of DT; and check if there is an improvement in the quality of sleep after the application of DT.

The aim is to collect a sample of more than 30 patients with fibromyalgia. Variables to be collected include the overall pain experienced by the patients (Visual Analog Scale), Presure Pain Threshold using an algometer of the right and left trochanteric prominence, the Fibromyalgia Impact Questionnaire (FIQ) measures the impact of FM, the Hospital Anxiety and Depression Scale (HADS) to measure anxiety and depression, the Pittsburgh Sleep Quality Questionnaire (PSQI) to measure sleep quality and the modified Fatigue Impact Scale (MFI-S) to measure self-reported general fatigue.

Subjects will be randomized into two groups: a control group (CG) that will not recive treatment and a experimental group (EU).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Experience chronic generalized pain and be diagnosed with FM for at least three months

排除标准

  • Recent surgery, skin conditions unsuitable for DT application, presence of certain neuropathic conditions (lupus, rheumatoid arthritis, diabetic polyneuropathy), ongoing pharmacological treatment such as anticoagulants within three days before participation, any underlying medical conditions like fractures or tumors; cardiac pathologies including heart failure, uncontrolled arterial hypertension, arrhythmias, phlebitis thrombi arteriopathies; having a pacemaker or suffering from epilepsy.

结局指标

主要结局

Pain (VAS)

时间窗: base line; after finish the treatment (4 weeks) and 15 days after completing treatment.

visal analogue scale, on a scale of 1-10, with higher scores indicating more pain.

Pain (algometry)

时间窗: base line; after finish the treatment (4 weeks) and 15 days after completing treatment.

Algometer, on a scale of 0-5. with higher scores indicating less pain.

次要结局

  • The impact of fibromyalgia.(base line; after finish the treatment (4 weeks) and 15 days after completing treatment.)
  • anxiety and depression(base line; after finish the treatment (4 weeks) and 15 days after completing treatment.)
  • sleep quality(base line; after finish the treatment (4 weeks) and 15 days after completing treatment.)
  • self-reported general fatigue(base line; after finish the treatment (4 weeks) and 15 days after completing treatment.)

研究者

发起方
Camilo Jose Cela University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验